Quick Pharm Flashcards
Basiliximab
Mab IL-2R
kidney transplant
edema, HTN, tremor
Oprelekin
IL-11
thrombocytopenia
Filgrastim
G-CSF
Sargramostim
GM-CSF
Aldesleukin
IL-2
renal cell carcinoma, metastatic melanoma
Alemtuzumab
Mab CD52
CLL
Bevacizumab
Mab VEGF
colorectal, renal cell
humoral injection for proliferative diabetic retinopathy and wet macula degeneration
Cetuximab
Mab EGFR
Colorectal IV, head/neck cancer
Rituximab
Mab CD20
B cell non-Hodgkin, RA (w/ MTX), ITP
Trastuzumab
Mab HER2/neu
breast and gastric cancer
Infliximab
Mab TNF-alpha
IBD, RA, ankylosing spondylitis, psoriatic arthritis
Adalimumab
Mab TNF-alpha
IBD, RA, ankylosing spondylitis, psoriatic arthritis
Natalizumab
Mab alpha4-integrin
MS, Crohn’s
! risk of PML in pt. w/ JC virus
Abciximab
Mab GpIIb/IIIa (anti-platelet clotting)
Denosumab
Mab RANKL
osteoperosis (mimic osteoprotegrin)
Omalizumab
Mab IgE (prevent IgE bind Fc-epsilon-RI on mast cell) allergic asthma
Palivizumab
Mab RSV F protein
prophylaxis in high risk children
-azole
ergosterol synthesis inhibitors (i.e. ketoconazole)
-bendazole
antiparasitic/antihelmintic (i.e. mebendazole)
-cillin
peptidoglycan synthesis inhibitor (i.e. ampicillin)
-cycline
protein synthesis inhibitor (i.e. tetracycline)
-ivir
neuraminidase inhibitor (i.e. oseltamivir)
-navir
protease inhibitor (i.e. ritonavir)
- ovir
DNA polymerase inhibitor (i.e. acyclovir)
-thromycin
macrolide antibiotic (i.e. azithromycin)
-ane
inhalation general anesthetic (i.e. halothane)
-azine
typical antipsychotics (i.e. thioridazine)
-barbital
barbituates (i.e. phenobarbital)
-caine
local anesthetic (i.e. lidocaine)
-etine
SSRI (i.e. fluoxetine)
-ipramine
TCA (i.e. imipramine)
-triptan
Seratonin1B/1D Agonist (i.e. sumatriptan)
-triptyline
TCA (i.e. amitripyline)
-zepam
BNZ (i.e. diazepam)
-zolam
BNZ (i.e. alprazolam)
-chol
cholinergic agonist (i.e. bethanechol/carbachol)
-curium/-curonium
non-depolarizing paralytic (i.e. atracurium/vecuronium)
-olol
beta-blocker (i.e. propanolol)
also inhibits peripheral conversion of T4
-stigmine
AChE Inhibitor (i.e. neostigmine)
-terol
beta2-agonist (i.e. albuterol)
-zosin
alpha1-antagonist (i.e. prazosin)
-afil
PDE-5 inhibitor (i.e. sildenafil)
-dipine
dihydropyridine CCB (i.e. amlodipine)
-pril
ACE inhibitors (i.e. captopril)
-sartan
AT-II receptor blocker (i.e. losartan)
-statin
HMG-CoA reductase inhibitor (i.e. atorvastatin)
-dronate
bisphosphonate (i.e. aldendronate)
-glitazone
PPAR-gamma activator (i.e. rosiglitazone)
-prazole
PPI (i.e. omeprazole)
-prost
PG analog (i.e. latanoprost)
-tidine
H2-antagonist (i.e. cimetidine)
-tropin
pituitary hormone (i.e. somatotropin)
-ximab
chimeric mAb (i.e. basiliximab)
-zumab
humanized mAb (i.e. daclizumab)
Fenoldopam
D1 Agonist at coronary, peripheral, renal and splanchinic vasodilation -> dec BP and inc natriuresis
Bile Acid Resin
cholestyramine, colestipol, colesevelam
bad taste, dec fat soluble vitamins, cholesterol gallstones
Cholesterol Absorption Blocker
ezetimibe
inc. LFT, diarrhea
Fibrates
gemfibrozil, clofibrate, bezafibrate, fenofibrate
Inc LPL adn activate PPAR-alpha (inc HDL)
myositis, hepatotoxicity, cholesterol gallstones
Class IA antiarrhythmics
quinindine, procainamide, disopyramide
inc. refractory, duration, QT
cinchonism, SLE-like, heartfailure, thrombocytopenia, torsades
Class IB antiarrhythmics
lidocaine, mexiletine
dec duration
best post-MI
CV depression
Class IC antiarrhythmics
flecainide, propafenone
prolong refractory, same duration
Contra structural heart disease (not MI)
Class III antiarrhythmics
amiodarone, ibutilide, dofetilide, sotalol
inc. duration, refractory, QT
use as last resort
Amiodarone ADE
pulmonary fibrosis, hepatotoxicity, hypo/hyperthyroidism, corneal deposits, skin deposits, photodermatitis, neuro effects, constipation, bradycardia, heart block, CHF
Minor Class I, II, IV effect also
disrupt lipid membrane
Adenosine
Inc K out of cell -> hyperpolarize, abolish supraVTach
very short action (15sec)